Digital phenotyping in young breast cancer patients treated with neoadjuvant chemotherapy (the NeoFit Trial): protocol for a national, multicenter single-arm trial

Digital phenotyping in young breast cancer patients treated with neoadjuvant chemotherapy (the NeoFit Trial): protocol for a national, multicenter single-arm trial

Background: Breast cancer (BC) has particular characteristics in young women, with diagnosis at more advanced stages, a poorer prognosis and highly aggressive tumors. In NeoFit, we will use an activity tracker to identify and describe various digital profiles (heart rate, physical activity, and slee...

Full description

Bibliographic Details
Main Authors: Antero, J. (Author), Asselain, B. (Author), Coussy, F. (Author), De Villèle, P. (Author), Delrieu, L. (Author), Dumas, E. (Author), Forstmann, N. (Author), Guérin, J. (Author), Hamy, A.-S (Author), Hotton, J. (Author), Jouannaud, C. (Author), Kassara, A. (Author), Laas, E. (Author), Leopold, A. (Author), Milder, M. (Author), Reyal, F. (Author), Sedeaud, A. (Author), Soibinet, P. (Author), Toussaint, J.-F (Author), Vercamer, V. (Author)
Format: Article
Language:English
Published: BioMed Central Ltd 2022
Subjects:
Activity trackers
Breast cancer
Digital
Neoadjuvant
Prevention
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items